DW6012

Dong Wha Pharmaceutical Co. Ltd. · Phase 1 active Small molecule

At a glance

Generic name	DW6012
Also known as	Dapagliflozin and Sitagliptin
Sponsor	Dong Wha Pharmaceutical Co. Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

DW6012 CI brief — competitive landscape report
DW6012 updates RSS · CI watch RSS
Dong Wha Pharmaceutical Co. Ltd. portfolio CI